The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study Academic Article uri icon

Overview

MeSH Major

  • HIV Infections
  • Heart Failure
  • Liver Cirrhosis

abstract

  • DAA treatment is not associated with a higher risk of HCC in persons with cirrhosis with chronic HCV infection in the short term. Previously reported higher rates of HCC associated with DAA treatment may be explained by both the presence of relatively fewer baseline HCC risk factors in persons treated with IFN as well as selection bias, given that DAA regimens were used to treat persons at higher risk for developing HCC. (Hepatology 2018;67:2244-2253).

publication date

  • June 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/hep.29707

PubMed ID

  • 29205416

Additional Document Info

start page

  • 2244

end page

  • 2253

volume

  • 67

number

  • 6